Scancell Holdings plc (AIM: SCLP)
Health Care · Biotechnology · GB
£0.09
+0.54% today · -4.6% 1Y
Scancell Holdings plc (AIM: SCLP) operates in the Biotechnology industry within the Health Care sector. The company is valued at $149.18M.
Over the last twelve months the share price has lost 4.6%, trading between 0.09 and 0.30.
Tweenvest scores Scancell Holdings plc across four factors: quality 15/100, value 54/100. Its strongest factor is value.
SCLP price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $149.18M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.02
- Dividend yield
- —
- Beta (5Y)
- 0.69
- 52-week high
- £0.30
- 52-week low
- £0.09
- Avg volume (3M)
- —
- Shares outstanding
- 1.21B
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| NovaBridge BiosciencesNasdaqGM: NBP | $153.12M | $1.32 | -5.38% |
| BioInvent International AB (publ)OM: BINV | $152.68M | Skr23.10 | -0.43% |
| Minerva Neurosciences, Inc.NasdaqCM: NERV | $151.84M | $2.89 | -9.12% |
| Essex Bio-Technology LimitedSEHK: 1061 | $149.73M | HK$2.08 | -3.26% |
| Molecular Partners AGSWX: MOLN | $148.00M | CHF3.21 | -3.60% |
| Actinogen Medical LimitedASX: ACW | $147.68M | AU$0.06 | +1.85% |
| JW (Cayman) Therapeutics Co. LtdSEHK: 2126 | $146.12M | HK$2.83 | +5.21% |
| Acumen Pharmaceuticals, Inc.NasdaqGS: ABOS | $146.08M | $2.02 | -5.61% |
Figures last refreshed Oct 11, 2026.